By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that revenues for the third quarter grew 13 percent to $2.97 billion, but lowered its revenue and EPS estimates for full-year 2011 reflecting weakness in the academic/government market.

Revenues for the three months ended Oct. 1 compare to $2.63 billion from the year ago period and missed analyst estimates of $3 billion for the quarter.

Organically, revenues grew 3 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.